UKSH Foundation funds state-of-the-art technology for the Departments of Urology, Surgery and Gynecology at Campus Kiel. Thanks to funding provided by the Foundation of University Medical Center Schleswig-Holstein (UKSH) the hospital has been able to upgrade an existing laparoscopy system in the interdisciplinary operating room at Campus Kiel with an ultra-modern 3D camera system. Yesterday evening, on March 4, 2015, a ceremony took place to mark the handover of the system.
"The state-of-the-art technology benefits our patients since it makes operating safer and recovery times are shortened," says Prof. Dr. Jens Scholz, Chairman of the Board of UKSH. "We are especially grateful to the trustees of the UKSH Foundation. They assume social responsibility for those that are in urgent need of university medicine."
"The innovative 3D system makes operating easier and faster," says Prof. Dr. Klaus-Peter Jünemann, Director of the Department of Urology and Pediatric Urology at Campus Kiel. "We are very pleased that, thanks to the UKSH Foundation, we can now immediately offer our patients this new technology and thus even higher surgical quality."
For patients, the introduction of 3D imaging in so-called keyhole surgery means greater safety and faster recovery. The technology enables surgeons to perceive depth and provides a precise spatial depiction of the anatomy which is not possible with traditional 2D systems. Dr. Carsten Maik Naumann, Senior Physician at the Department of Urology and Pediatric Urology, explains: "The modern camera enables me as a surgeon to greatly improve my hand and eye coordination. I do not tire as quickly and at the same time I can operate even more precisely."
"We greatly appreciate the important role that the UKSH plays for the people and businesses in our region and are pleased to support this strong position by funding this project as well," said Alexander Eck, Chairman of the UKSH Foundation's Board, in the name of all trustees at the ceremony to mark the handing over of the 3D laparoscopy unit. The UKSH Foundation assumed all the costs of EUR 80,919.00 to enable the hospital to purchase the 3D imaging system.
"Anyone else who wishes to support top-class medicine at the UKSH is warmly invited to join the group of trustees and supporters of the UKSH Foundation," says Pit Horst, head of the UKSH's fundraising unit and Managing Director of the Foundation. "We will gladly arrange a meeting with anyone interested in taking this step."
The 3D endoscope developed by Olympus features a flexible instrument tip that can bend up to 100 degrees in four directions. Besides the three-dimensional view, it also greatly simplifies identification of the anatomy for the surgeon. Like UKSH's da Vinci surgical system, the new 3D laparoscopy unit will be used on an interdisciplinary basis by the Departments of Urology, Surgery and Gynecology at Campus Kiel. It is therefore available to provide the best possible treatment to all patients of the three departments. Laparoscopic surgery is a field of surgery involving procedures within the abdominal cavity using an optical instrument to avoid the need for major surgical incisions. It is assigned to the field of minimally invasive surgery.
The Foundation was established on May 29, 2013 by 16 private persons and 13 companies to provide long-term support to top-class medicine at the UKSH as founding benefactors and trustees. As of the date of establishment, the Foundation's assets amounted to EUR 290,000. Thanks to year support of the now 34 trustees, further contributions and income from the Foundation assets, the Foundation provided funding of more than EUR 200,000 to enable five top-class medicine projects at UKSH in Kiel and Lübeck to be realized.
Donation accounts of the UKSH Foundation Recipient: Förderstiftung des UKSH Förde Sparkasse: account no.: 1 400 142 988 | BLZ: 210 501 70 IBAN: DE10 2105 0170 1400 1429 88 | BIC: NOLADE21KIE
Please address questions to: Förderstiftung des UKSH c/o Fundraising Unit at UKSH Managing Director Dipl.-Kfm. Pit Horst, tel.: 0431 597-1004, e-mail: pit.horst@uksh.de or kuratorium@uksh.de
More News
GQ Bio is pioneering a high-capacity adenovirus (HCAd) gene therapy vector platform that addresses some of the big challenges in the gene therapy field. (Picture: GQ Bio)
HTGF portfolio company GQ Bio, pioneering a high-capacity adenovirus gene therapy vector platform, was acquired by Pacira BioSciences, Inc. Pacira, the industry leader in its ...
At its new premises in the tecHHub Hamburg, CrystalsFirst is significantly expanding its operations to foster greater synergy. (Picture: CrystalsFirst)
CrystalsFirst, a leading provider of advanced structural biology solutions and AI-driven drug discovery, is pleased to announce a multi-million-euro expansion of its laboratory infrastructure and ...
medac has received FDA approval for treosulfan as a new drug application with orphan drug designation prior to allogeneic hematopoietic stem cell transplantation (alloHSCT) in ...